市場調査レポート

世界の細胞表面マーカー(フローサイトメーター、血液分析器、試薬およびキット)市場:産業分析・市場規模・シェア・成長・動向・予測

Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents and Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

発行 Transparency Market Research 商品コード 279218
出版日 ページ情報 英文 108 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
世界の細胞表面マーカー(フローサイトメーター、血液分析器、試薬およびキット)市場:産業分析・市場規模・シェア・成長・動向・予測 Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents and Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
出版日: 2013年08月26日 ページ情報: 英文 108 Pages
概要

細胞表面マーカー市場は、技術及びソリューションの急速な自動化、データ管理の簡略化に加えて、特定の病気の治療において迅速かつ効果的な決定を行うという視点から、ますます医療支出を削減しようという傾向が進むことにより、世界中で驚異的な成長を遂げています。その一方で、癌や自己免疫疾患などの慢性疾患の高い罹患率が、世界的に細胞表面マーカーによる分析に対する高い需要を促しています。

当レポートでは、世界の細胞表面マーカー(フローサイトメーター、血液分析器、試薬およびキット)市場の現状と見通しについて調査分析し、市場成長促進要因・阻害要因および市場機会の分析、器具・試薬別・アプリケーション別・地域別の市場分析、主要企業のプロファイルをまとめるなど、概略以下の構成でお届けいたします。

第1章 イントロダクション

  • 調査の説明
  • 市場区分
  • 調査手法
  • 略語集

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場動向と将来の見通し
  • 世界の細胞表面マーカー市場売上、器具・試薬別、2011-2019年(百万米ドル)
  • 市場成長促進要因
  • 市場成長阻害要因
  • 市場機会
  • 世界の細胞表面マーカー市場に関するポーターのファイブフォース分析
  • 世界の細胞表面マーカー市場の市場魅力分析、器具・試薬別:2012年

第4章 世界の細胞表面マーカー市場、器具・試薬別

  • 概要:現在の市場シナリオと将来の市場動向
  • フローサイトメトリー
  • 血液分析器
  • 試薬およびキット

第5章 世界の細胞表面マーカー市場:アプリケーション別

  • 病気の診断
  • 研究および創薬

第6章 世界の細胞表面マーカー市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • 世界のその他地域(RoW)

第7章 提言

第8章 企業プロファイル

  • Abbott Laboratories, Inc.
  • Beckman Coulter, Inc.
  • BD Biosciences
  • Bio-Rad Laboratories, Inc.
  • Grifols SA
  • Immucor, Inc.
  • Janssen Diagnostics, Inc.
  • 日本光電
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare
  • Sysmex Corporation
  • Thermo Fischer Scientific, Inc.

図表

目次

The cell surface markers market is undergoing impressive growth across the globe due to rapid automation of technologies and solutions, simplification of data management coupled with increasing preference for reduction of healthcare spending with a view to provide rapid and efficient decision making for therapies for specific diseases. On the other hand, high prevalence of chronic diseases such as cancer and autoimmune disorders has resulted in an elevated demand for cell surface markers analysis worldwide. Since their introduction, cell surface makers study has undergone tremendous technological development, and it is expected that soon end-users will be benefited from the increasing scope of applications of cell surface markers.

This report studies the cell surface markers market by the types of products commercially available for cell markers analysis. Each of the segments has been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD million. The CAGR (%) of all segments has been provided for the forecast period of 2013 to 2019, considering 2012 as the base year.

In terms of geography, this market has been classified into North America, Europe, Asia-Pacific and Rest of the World (RoW) regions. The respective market size for each region and their forecast till 2019 has also been presented in the report. In addition, a qualitative assessment of the market dynamics of the cell surface markers market has been provided, wherein the drivers, restraints, opportunities and market attractiveness has been studied.

The competitive landscape section of this report provides a bird's eye view of the major market players currently operating in this market and their respective products. Also, a pipeline snapshot of new entrants in this market along with their development stage products has been included. Some of the key market players profiled in this report include Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., Grifols SA, Immucor, Inc. and Janssen Diagnostics, Inc.

Table of Contents

Chapter 1 - Introduction

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. List of Abbreviations

Chapter 2 - Executive Summary

Chapter 3 - Market Overview

  • 3.1. Market Trends and Future Outlook
  • 3.2. Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 - 2019 (USD Million)
  • 3.3. Drivers
    • 3.3.1. Growing Automation in Laboratories
    • 3.3.2. Discovery of New Markers will Need New Antibodies
    • 3.3.3. Increased Use of In Vitro Diagnostics
    • 3.3.4. Need for Lowering Healthcare Expenditure
  • 3.4. Restraints
    • 3.4.1. Reluctance for High Investment in Sophisticated Models
    • 3.4.2. Complexity in the Use of Flow Cytometers
  • 3.5. Opportunities
    • 3.5.1. Growth in Expertise for Operation of Cell Marking Tools
    • 3.5.2. Targeted Therapy and Personalized Medicine
  • 3.6. Porter's Five Force Analysis for the Global Cell Surface Markers Market
    • 3.6.1. Bargaining Power of Suppliers
    • 3.6.2. Bargaining Power of Buyers
    • 3.6.3. Threat of New Entrants
    • 3.6.4. Threat of Substitutes
    • 3.6.5. Competitive Rivalry
  • 3.7. Market Attractiveness Analysis of Global Cell Surface Markers Market, by Instruments and Reagents, 2012

Chapter 4 - Global Cell Surface Markers Market, by Instruments and Reagents

  • 4.1. Overview - Current Market Scenario and Future Market Trends
    • 4.1.1. Global Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
  • 4.2. Flow Cytometry
    • 4.2.1. Global Flow Cytometers Market Revenues, 2013 - 2019 (USD Million)
    • 4.2.2. Global Flow Cytometers Market Volume, 2013 - 2019 (Number of Units Installed)
  • 4.3. Hematology Analyzers
    • 4.3.1. Global Hematology Analyzers Market Revenues, 2011 - 2019 (USD Million)
    • 4.3.2. Global Hematology Analyzers Market Volume, 2013 - 2019 (Number of Units Installed)
  • 4.4. Reagents and Kits
    • 4.4.1. Global Reagent and Kits Market Revenues, 2011 - 2019 (USD Million)

Chapter 5 - Global Cell Surface Markers Market, by Applications

  • 5.1. Disease Diagnosis
    • 5.1.1. Global Cell Surface Markers Market Revenues, by Disease Diagnosis and Identification, 2011 - 2019 (USD Million)
  • 5.2. Research and Drug Discovery
    • 5.2.1. Global Cell Surface Markers Market Revenues, by Research and Drug Discovery, 2011 - 2019 (USD Million)

Chapter 6 - Global Cell Surface Markers Market, by Geography

  • 6.1. Introduction
  • 6.2. North America
    • 6.2.1. North America Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Cell Surface Markers Market Revenues, Size and Forecast, 2011 - 2019 (USD Million)
  • 6.4. Asia-Pacific
    • 6.4.1. Asia-Pacific Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
  • 6.5. Rest of the World (RoW)
    • 6.5.1. Rest of the World (RoW) Cell Surface Markers Market Revenues, Size and Forecast, 2011 - 2019 (USD Million)

Chapter 7 - Recommendations

Chapter 8 - Company Profiles

  • 8.1. Abbott Laboratories, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Strategic Overview
    • 8.1.3. Financial Overview
    • 8.1.4. Product Portfolio
    • 8.1.5. Recent Developments
  • 8.2. Beckman Coulter, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Strategic Overview
    • 8.2.3. Financial Overview
    • 8.2.4. Product Portfolio
    • 8.2.5. Recent Developments
  • 8.3. BD Biosciences
    • 8.3.1. Company Overview
    • 8.3.2. Strategic Overview
    • 8.3.3. Financial Overview
    • 8.3.4. Product Portfolio
    • 8.3.5. Recent Development
  • 8.4. Bio-Rad Laboratories, Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Strategic Overview
    • 8.4.3. Financial Overview
    • 8.4.4. Product Portfolio
    • 8.4.5. Recent Development
  • 8.5. Grifols SA
    • 8.5.1. Company Overview
    • 8.5.2. Strategic Overview
    • 8.5.3. Financial Overview
    • 8.5.4. Product Portfolio
    • 8.5.5. Recent Development
  • 8.6. Immucor, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Strategic Overview
    • 8.6.3. Financial Overview
    • 8.6.4. Product Portfolio
    • 8.6.5. Recent Developments
  • 8.7. Janssen Diagnostics, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Strategic Overview
    • 8.7.3. Financial Overview
    • 8.7.4. Product Portfolio
    • 8.7.5. Recent development
  • 8.8. Nihon Kohden Corporation
    • 8.8.1. Company Overview
    • 8.8.2. Strategic Overview
    • 8.8.3. Financial Overview
    • 8.8.4. Product Portfolio
    • 8.8.5. Recent developments
  • 8.9. F. Hoffmann-La Roche Ltd.
    • 8.9.1. Company Overview
    • 8.9.2. Strategic Overview
    • 8.9.3. Financial Overview
    • 8.9.4. Product Portfolio
    • 8.9.5. Recent Developments
  • 8.10. Siemens Healthcare
    • 8.10.1. Company Overview
    • 8.10.2. Strategic Overview
    • 8.10.3. Financial Overview
    • 8.10.4. Product Portfolio
    • 8.10.5. Recent Developments
  • 8.11. Sysmex Corporation
    • 8.11.1. Company Overview
    • 8.11.2. Strategic Overview
    • 8.11.3. Financial Overview
    • 8.11.4. Product Portfolio
    • 8.11.5. Recent Development
  • 8.12. Thermo Fischer Scientific, Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Strategic Overview
    • 8.12.3. Financial Overview
    • 8.12.4. Product Portfolio
    • 8.12.5 Recent Development

LIST OF FIGURE

  • FIG. 1: Cell Surface Markers: Market Segmentation
  • FIG. 2: Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2012 (USD Million)
  • FIG. 3: Global Cell Surface Markers Market Revenues, by Geography, 2012 (USD Million)
  • FIG. 4: Porter's Five Force Analysis: Global Cell Surface Markers Market
  • FIG. 5: Market Attractive Analysis: Global Cell Surface Markers Market, by Instruments and Reagents, 2012
  • FIG. 6: Global Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
  • FIG. 7: Global Flow Cytometers Market Revenues, 2011 - 2019 (USD Million)
  • FIG. 8: Global Flow Cytometers Market Volume, 2011 - 2019 (Number of Units Installed)
  • FIG. 9: Global Hematology Analyzers Market Revenues, 2011 - 2019 (USD Million)
  • FIG. 10: Global Hematology Analyzers Market Volume, 2011 - 2019 (Number of Units Installed)
  • FIG. 11: Global Reagents and Kits Market Revenues, 2011 - 2019 (USD Million)
  • FIG. 12: Global Cell Surface Markers Market Revenues, by Disease Diagnosis and Identification, 2011 - 2019 (USD Million)
  • FIG. 13: Global Cell Surface Markers Market Revenues, by Research and Drug Discovery, 2011 - 2019 (USD Million)
  • FIG. 14: North America Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
  • FIG. 15: Europe Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
  • FIG. 16: Asia-Pacific Cell Surface Markers Market Revenues, 2011 - 2019(USD Million)
  • FIG. 17: Rest of the World (RoW) Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
  • FIG. 18: Annual Revenues of Abbott Laboratories, Inc., 2010 - 2012 (USD Million)
  • FIG. 19: Annual Revenues of Bio-Rad Laboratories, Inc., 2010 - 2012 (USD Million)
  • FIG. 20: Annual Revenues of Grifols SA, 2010 - 2012 (USD Million)
  • FIG. 21: Annual Revenues of Immucor, Inc., 2010 - 2012 (USD Million)
  • FIG. 22: Annual Revenues of Nihon Kohden Corp., 2010 - 2012 (USD Million)
  • FIG. 23: Annual Revenues of Hoffmann-La Roche Ltd., 2010 - 2012 (USD Million)
  • FIG. 24: Annual Revenues of Siemens Healthcare, 2010 - 2012 (USD Million)
  • FIG. 25: Annual Revenues of Sysmex Corporation, 2010 - 2012 (USD Million)
  • FIG. 26: Annual Revenues of Thermo Fischer Scientific, Inc., 2010 - 2012 (USD Million)

LIST OF TABLE

  • TABLE 1: Market Snapshot: Global Cell Surface Markers Market
  • TABLE 2: Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 - 2019 (USD Million)
  • TABLE 3: Global Cell Surface Markers Market Revenues, by Geography, Size and Forecast, 2013-2019 (USD Million)
  • TABLE 4: North America Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 - 2019 (USD Million)
  • TABLE 5: Europe Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 - 2019 (USD Million)
  • TABLE 6: Asia-Pacific Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 - 2019 (USD Million)
  • TABLE 7: RoW Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 - 2019 (USD Million)
Back to Top